Biotechnological war against biofilms. Could phages mean the end of device-related infections?

J. L. Del Pozo, M. Alonso, C. R. Arciola, R. Gonzalez, J. Leiva, I. Lasa, J. Penades

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Microorganisms universally attach to surfaces, resulting in biofilm formation. These biofilms entail a serious problem in daily clinical practice because of the great prevalence of implantable device-related infections. Differences in antibiotic activity against planktonic and sessile bacteria may relate to clinical failures in the treatment of biofilm-related infections (BRI). Bacteriophages have several characteristics that make them potentially attractive therapeutic agents in some selected clinical settings, like for example BRI. They are highly specific and very effective in lysing targeted bacteria, moreover, they appear to be safe for humans. Many studies have shown the potential of phages for the treatment of infectious diseases in plants and animals, including infections with highly drug-resistant bacteria. The therapeutic use of bacteriophages, possibly in combination with antibiotics, may be a valuable approach in BRI. However, many important questions still remain that must be addressed before phages can be endorsed for therapeutic use in humans.

Original languageEnglish
Pages (from-to)805-812
Number of pages8
JournalInternational Journal of Artificial Organs
Volume30
Issue number9
Publication statusPublished - Sep 2007

Fingerprint

Bacteriophages
Biofilms
Equipment and Supplies
Infection
Bacteria
Therapeutic Uses
Antibiotics
Anti-Bacterial Agents
Treatment Failure
Microorganisms
Communicable Diseases
Animals
Warfare
Pharmaceutical Preparations

Keywords

  • Biofilm
  • Phages
  • Staphylococcus aureus

ASJC Scopus subject areas

  • Biophysics

Cite this

Del Pozo, J. L., Alonso, M., Arciola, C. R., Gonzalez, R., Leiva, J., Lasa, I., & Penades, J. (2007). Biotechnological war against biofilms. Could phages mean the end of device-related infections? International Journal of Artificial Organs, 30(9), 805-812.

Biotechnological war against biofilms. Could phages mean the end of device-related infections? / Del Pozo, J. L.; Alonso, M.; Arciola, C. R.; Gonzalez, R.; Leiva, J.; Lasa, I.; Penades, J.

In: International Journal of Artificial Organs, Vol. 30, No. 9, 09.2007, p. 805-812.

Research output: Contribution to journalArticle

Del Pozo, JL, Alonso, M, Arciola, CR, Gonzalez, R, Leiva, J, Lasa, I & Penades, J 2007, 'Biotechnological war against biofilms. Could phages mean the end of device-related infections?', International Journal of Artificial Organs, vol. 30, no. 9, pp. 805-812.
Del Pozo, J. L. ; Alonso, M. ; Arciola, C. R. ; Gonzalez, R. ; Leiva, J. ; Lasa, I. ; Penades, J. / Biotechnological war against biofilms. Could phages mean the end of device-related infections?. In: International Journal of Artificial Organs. 2007 ; Vol. 30, No. 9. pp. 805-812.
@article{f23e1699e5844ea3b9b753859f209b9e,
title = "Biotechnological war against biofilms. Could phages mean the end of device-related infections?",
abstract = "Microorganisms universally attach to surfaces, resulting in biofilm formation. These biofilms entail a serious problem in daily clinical practice because of the great prevalence of implantable device-related infections. Differences in antibiotic activity against planktonic and sessile bacteria may relate to clinical failures in the treatment of biofilm-related infections (BRI). Bacteriophages have several characteristics that make them potentially attractive therapeutic agents in some selected clinical settings, like for example BRI. They are highly specific and very effective in lysing targeted bacteria, moreover, they appear to be safe for humans. Many studies have shown the potential of phages for the treatment of infectious diseases in plants and animals, including infections with highly drug-resistant bacteria. The therapeutic use of bacteriophages, possibly in combination with antibiotics, may be a valuable approach in BRI. However, many important questions still remain that must be addressed before phages can be endorsed for therapeutic use in humans.",
keywords = "Biofilm, Phages, Staphylococcus aureus",
author = "{Del Pozo}, {J. L.} and M. Alonso and Arciola, {C. R.} and R. Gonzalez and J. Leiva and I. Lasa and J. Penades",
year = "2007",
month = "9",
language = "English",
volume = "30",
pages = "805--812",
journal = "International Journal of Artificial Organs",
issn = "0391-3988",
publisher = "Wichtig Publishing",
number = "9",

}

TY - JOUR

T1 - Biotechnological war against biofilms. Could phages mean the end of device-related infections?

AU - Del Pozo, J. L.

AU - Alonso, M.

AU - Arciola, C. R.

AU - Gonzalez, R.

AU - Leiva, J.

AU - Lasa, I.

AU - Penades, J.

PY - 2007/9

Y1 - 2007/9

N2 - Microorganisms universally attach to surfaces, resulting in biofilm formation. These biofilms entail a serious problem in daily clinical practice because of the great prevalence of implantable device-related infections. Differences in antibiotic activity against planktonic and sessile bacteria may relate to clinical failures in the treatment of biofilm-related infections (BRI). Bacteriophages have several characteristics that make them potentially attractive therapeutic agents in some selected clinical settings, like for example BRI. They are highly specific and very effective in lysing targeted bacteria, moreover, they appear to be safe for humans. Many studies have shown the potential of phages for the treatment of infectious diseases in plants and animals, including infections with highly drug-resistant bacteria. The therapeutic use of bacteriophages, possibly in combination with antibiotics, may be a valuable approach in BRI. However, many important questions still remain that must be addressed before phages can be endorsed for therapeutic use in humans.

AB - Microorganisms universally attach to surfaces, resulting in biofilm formation. These biofilms entail a serious problem in daily clinical practice because of the great prevalence of implantable device-related infections. Differences in antibiotic activity against planktonic and sessile bacteria may relate to clinical failures in the treatment of biofilm-related infections (BRI). Bacteriophages have several characteristics that make them potentially attractive therapeutic agents in some selected clinical settings, like for example BRI. They are highly specific and very effective in lysing targeted bacteria, moreover, they appear to be safe for humans. Many studies have shown the potential of phages for the treatment of infectious diseases in plants and animals, including infections with highly drug-resistant bacteria. The therapeutic use of bacteriophages, possibly in combination with antibiotics, may be a valuable approach in BRI. However, many important questions still remain that must be addressed before phages can be endorsed for therapeutic use in humans.

KW - Biofilm

KW - Phages

KW - Staphylococcus aureus

UR - http://www.scopus.com/inward/record.url?scp=36048965115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36048965115&partnerID=8YFLogxK

M3 - Article

C2 - 17918126

AN - SCOPUS:36048965115

VL - 30

SP - 805

EP - 812

JO - International Journal of Artificial Organs

JF - International Journal of Artificial Organs

SN - 0391-3988

IS - 9

ER -